• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    J.M. SmuckerPosts Upbeat Earnings, Joins Toro Company, United Natural Foods, Semtech And Other Big Stocks Moving Higher On Thursday

    6/6/24 10:44:48 AM ET
    $CART
    $CIEN
    $HALO
    $HOOD
    Real Estate
    Real Estate
    Telecommunications Equipment
    Utilities
    Get the next $CART alert in real time by email

    U.S. stocks were slightly higher, with the Dow Jones index gaining around 0.1% on Thursday.

    Shares of The J. M. Smucker Company (NYSE:SJM) rose sharply during Thursday’s session following upbeat quarterly earnings.

    The company reported a fourth-quarter FY24 sales decline of 1.3% year-on-year to $2.21 billion, missing the analyst consensus estimate of $2.24 billion. Adjusted EPS of $2.66 beat the analyst consensus estimate of $2.33, according to data from Benzinga Pro.

    Smucker shares climbed 6.2% to $117.16 on Thursday.

    Here are some other big stocks recording gains in today’s session.

    • Latam Logistic Properties, S.A. (NYSE:LPA) shares surged 99.2% to $63.01 after dipping around 83% on Wednesday.
    • Replimune Group, Inc. (NASDAQ:REPL) rose 27.3% to $7.08 as the company announced positive topline primary analysis data by Independent Central Review from IGNYTE clinical trial of RP1 plus nivolumab in anti-PD1 failed melanoma.
    • SecureWorks Corp. (NASDAQ:SCWX) gained 20.3% to $7.04 following upbeat quarterly results.
    • Smartsheet Inc. (NYSE:SMAR) rose 18.8% to $44.90 after the company reported better-than-expected first-quarter financial results and announced an inaugural $150 million share repurchase program.
    • Xponential Fitness, Inc. (NYSE:XPOF) climbed 18.1% to $11.65.
    • Pharming Group N.V. (NASDAQ:PHAR) surged 13.8% to $8.74.
    • Halozyme Therapeutics, Inc. (NASDAQ:HALO) jumped 10.8% to $50.60 after the company raised its FY24 guidance.
    • The Toro Company (NYSE:TTC) gained 8% to $85.97 after the company reported better-than-expected second-quarter EPS and sales.
    • United Natural Foods, Inc. (NYSE:UNFI) climbed 7.1% to $14.35. Roth MKM analyst Bill Kirk maintained United Natural Foods with a Neutral and raised the price target from $13 to $14.
    • Maplebear Inc. (NASDAQ:CART) rose 6.7% to $33.02 after the company approved a $500 million share repurchase program.
    • Semtech Corporation (NASDAQ:SMTC) rose 6.7% to $41.28 after the company reported better-than-expected first-quarter financial results.
    • iRhythm Technologies, Inc. (NASDAQ:IRTC) gained 5.8% to $95.83.
    • Robinhood Markets, Inc. (NASDAQ:HOOD) shares climbed 5% to $22.65 after the company announced it will acquire cryptocurrency exchange Bitstamp.
    • Lyft, Inc. (NASDAQ:LYFT) rose 4.8% to $16.28 after the company provided 2027 financial targets ahead of its Investor Day.
    • Illumina, Inc. (NASDAQ:ILMN) gained 4.7% to $111.78.
    • Ciena Corporation (NYSE:CIEN) rose 4.3% to $50.32 following upbeat quarterly results.
    • Lululemon Athletica Inc. (NASDAQ:LULU) shares gained 3.5% to $319.05 as the company reported upbeat financial results for its first quarter and authorized a $1 billion increase in its stock repurchase program.

    Now Read This: Jim Cramer Recommends Buying PNC Financial Services, Calls MasTec A ‘Great Infrastructure Play‘

    Get the next $CART alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CART
    $CIEN
    $HALO
    $HOOD

    CompanyDatePrice TargetRatingAnalyst
    Replimune Group Inc.
    $REPL
    4/13/2026$1.00Market Perform → Underperform
    BMO Capital Markets
    Replimune Group Inc.
    $REPL
    4/13/2026$2.00Buy → Hold
    Jefferies
    Replimune Group Inc.
    $REPL
    4/13/2026Neutral → Underweight
    Analyst
    Replimune Group Inc.
    $REPL
    4/13/2026Buy → Sell
    H.C. Wainwright
    Replimune Group Inc.
    $REPL
    4/13/2026$2.00Outperform → Market Perform
    Leerink Partners
    Replimune Group Inc.
    $REPL
    4/13/2026$2.00Outperform → Neutral
    Wedbush
    Replimune Group Inc.
    $REPL
    4/10/2026$4.00Overweight → Neutral
    Piper Sandler
    Pharming Group N.V. ADS each representing 10
    $PHAR
    4/10/2026$37.00Buy
    Canaccord Genuity
    More analyst ratings

    $CART
    $CIEN
    $HALO
    $HOOD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Amin Tarang bought $99,801 worth of shares (880 units at $113.41), increasing direct ownership by 23% to 4,705 units (SEC Form 4)

    4 - J M SMUCKER Co (0000091419) (Issuer)

    3/3/26 4:41:12 PM ET
    $SJM
    Packaged Foods
    Consumer Staples

    Chief Executive Officer Risher John David bought $100,179 worth of shares (7,490 units at $13.38), increasing direct ownership by 0.07% to 11,481,792 units (SEC Form 4)

    4 - Lyft, Inc. (0001759509) (Issuer)

    2/18/26 4:10:21 PM ET
    $LYFT
    Real Estate

    Director Gottlieb Scott bought $23,562 worth of shares (200 units at $117.81), increasing direct ownership by 2% to 12,723 units (SEC Form 4)

    4 - ILLUMINA, INC. (0001110803) (Issuer)

    2/11/26 4:04:54 PM ET
    $ILMN
    Medical Specialities
    Health Care

    $CART
    $CIEN
    $HALO
    $HOOD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Replimune downgraded by BMO Capital Markets with a new price target

    BMO Capital Markets downgraded Replimune from Market Perform to Underperform and set a new price target of $1.00

    4/13/26 8:45:13 AM ET
    $REPL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Replimune downgraded by Jefferies with a new price target

    Jefferies downgraded Replimune from Buy to Hold and set a new price target of $2.00

    4/13/26 8:45:13 AM ET
    $REPL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Replimune downgraded by Analyst

    Analyst downgraded Replimune from Neutral to Underweight

    4/13/26 8:45:13 AM ET
    $REPL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $CART
    $CIEN
    $HALO
    $HOOD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma

    WOBURN, Mass., April 10, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ:REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the company received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) for the Company's Biologics License Application (BLA) for RP1 in combination with nivolumab for the treatment of advanced melanoma. Replimune disagrees with the FDA about whether the data set, upon which breakthrough therapy designation was awarded, is sufficient to allow this promising medicine to be made available to advanced cancer patients. In the IGNYTE trial, patients with co

    4/10/26 5:02:32 PM ET
    $REPL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma

    WOBURN, Mass., April 10, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ:REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the company received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) for the Company's Biologics License Application (BLA) for RP1 in combination with nivolumab for the treatment of advanced melanoma. Replimune disagrees with the FDA about whether the data set, upon which breakthrough therapy designation was awarded, is sufficient to allow this promising medicine to be made available to advanced cancer patients. In the IGNYTE trial, patients with co

    4/10/26 5:02:32 PM ET
    $REPL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Instacart to Report First Quarter 2026 Financial Results on May 6, 2026

    SAN FRANCISCO, April 9, 2026 /PRNewswire/ -- Instacart (NASDAQ:CART) today announced it will report its first quarter 2026 financial results before market open on Wednesday, May 6, 2026. Instacart management will also host a conference call to discuss the company's results at 5:30 a.m. Pacific Time (8:30 a.m. Eastern Time) on Wednesday, May 6, 2026. To access a live webcast of the call, please visit Instacart's Investor Relations website at https://investors.instacart.com. After the call concludes, a replay will be made available on Instacart's Investor Relations website.Instaca

    4/9/26 4:45:00 PM ET
    $CART
    Real Estate

    $CART
    $CIEN
    $HALO
    $HOOD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Neuburger Nicole

    4 - lululemon athletica inc. (0001397187) (Issuer)

    4/9/26 5:14:29 PM ET
    $LULU
    Apparel
    Consumer Discretionary

    SEC Form 4 filed by Parent Haughey Nicole

    4 - Xponential Fitness, Inc. (0001802156) (Issuer)

    4/8/26 5:22:57 PM ET
    $XPOF
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    SEC Form 4 filed by Wilson John Michael

    4 - SEMTECH CORP (0000088941) (Issuer)

    4/8/26 5:09:08 PM ET
    $SMTC
    Semiconductors
    Technology

    $CART
    $CIEN
    $HALO
    $HOOD
    SEC Filings

    View All

    Amendment: SEC Form 20-F/A filed by Pharming Group N.V. ADS each representing 10

    20-F/A - Pharming Group N.V. (0001828316) (Filer)

    4/13/26 10:24:56 AM ET
    $PHAR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Replimune Group Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - Replimune Group, Inc. (0001737953) (Filer)

    4/10/26 5:59:21 PM ET
    $REPL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form DEFA14A filed by Lyft Inc.

    DEFA14A - Lyft, Inc. (0001759509) (Filer)

    4/10/26 4:10:30 PM ET
    $LYFT
    Real Estate

    $CART
    $CIEN
    $HALO
    $HOOD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by SecureWorks Corp.

    SC 13G/A - SecureWorks Corp (0001468666) (Subject)

    12/6/24 3:33:53 PM ET
    $SCWX
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Illumina Inc.

    SC 13G/A - ILLUMINA, INC. (0001110803) (Subject)

    12/6/24 10:11:24 AM ET
    $ILMN
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Illumina Inc.

    SC 13G - ILLUMINA, INC. (0001110803) (Subject)

    12/5/24 7:27:01 PM ET
    $ILMN
    Medical Specialities
    Health Care

    $CART
    $CIEN
    $HALO
    $HOOD
    Financials

    Live finance-specific insights

    View All

    Instacart to Report First Quarter 2026 Financial Results on May 6, 2026

    SAN FRANCISCO, April 9, 2026 /PRNewswire/ -- Instacart (NASDAQ:CART) today announced it will report its first quarter 2026 financial results before market open on Wednesday, May 6, 2026. Instacart management will also host a conference call to discuss the company's results at 5:30 a.m. Pacific Time (8:30 a.m. Eastern Time) on Wednesday, May 6, 2026. To access a live webcast of the call, please visit Instacart's Investor Relations website at https://investors.instacart.com. After the call concludes, a replay will be made available on Instacart's Investor Relations website.Instaca

    4/9/26 4:45:00 PM ET
    $CART
    Real Estate

    Illumina to Announce First Quarter 2026 Financial Results on Thursday, April 30, 2026

    SAN DIEGO, April 9, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) announced today that it will issue results for the first quarter 2026 following the close of market on Thursday, April 30, 2026. On the same day, at 1:30 pm Pacific Time (4:30 pm Eastern Time) Jacob Thaysen, PhD, Chief Executive Officer, and Ankur Dhingra, Chief Financial Officer, will host a conference call with analysts, investors, and other interested parties to discuss financial and operating results. Conference Call DetailsThe conference call will begin at 1:30 pm Pacific Time (4:30 pm Eastern Time) on Thursday, April 30, 2026. Interested parties may access the live webcast via the Investor Info section of Illumina's

    4/9/26 4:30:00 PM ET
    $ILMN
    Medical Specialities
    Health Care

    Robinhood Markets, Inc. to Announce First Quarter 2026 Results on April 28, 2026

    MENLO PARK, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- Today, Robinhood Markets, Inc. ("Robinhood") (NASDAQ:HOOD) announced that it will release its first quarter 2026 financial results on Tuesday, April 28, 2026, after market close. Robinhood will host a video call with Chairman & Chief Executive Officer Vlad Tenev and Chief Financial Officer Shiv Verma to discuss its results at 2:00 PM PT / 5:00 PM ET on the same day. The video call and supporting materials will be available at investors.robinhood.com. The event will also be live streamed to YouTube and X.com via Robinhood's official channels, @RobinhoodApp, and within the Robinhood mobile app. Following the call, a replay and transcript

    4/1/26 4:05:00 PM ET
    $HOOD
    Investment Bankers/Brokers/Service
    Finance

    $CART
    $CIEN
    $HALO
    $HOOD
    Leadership Updates

    Live Leadership Updates

    View All

    Xponential Fitness, Inc. Initiates Review of Strategic Alternatives to Maximize Shareholder Value

    Appoints Nicole Parent Haughey to Board of Directors Xponential Fitness, Inc. (NYSE:XPOF) ("Xponential" or the "Company"), one of the leading global franchisors of boutique health and wellness brands, today announced its Board of Directors has initiated a review of strategic alternatives to maximize shareholder value. As part of this process, the Board's independent directors will evaluate a range of potential alternatives, which may include a sale of the Company, a merger, or another strategic or financial transaction. The Company has engaged Jefferies LLC as its financial advisor for the strategic review process. Rachel Lee and Lily Yang, Independent Directors on Xponential's Board,

    4/6/26 8:00:00 PM ET
    $AIMC
    $ALLE
    $XPOF
    Industrial Machinery/Components
    Industrials
    Diversified Commercial Services
    Consumer Discretionary

    Chip Wilson Comments on lululemon's Board Changes and Fourth Quarter and Full Year Fiscal 2025 Results

    VANCOUVER, B.C., March 18, 2026 /CNW/ -- Chip Wilson, Founder of lululemon athletica inc. (NASDAQ:LULU) ("lululemon" or the "Company") and one of lululemon's largest shareholders, today issued the following statement regarding the Company's announcement of Board refreshment and fourth quarter and full year results. "As I have communicated publicly and privately for the past several months, lululemon is in dire need of significant and substantial refreshment of the board of directors. Yesterday's announcement that David Mussafer, an overly long-tenured director with more than 14 years of total service on the Board, will not seek re-election, is another step of welcome change. His influence on

    3/18/26 8:00:00 AM ET
    $LULU
    Apparel
    Consumer Discretionary

    Chip Bergh Joins lululemon Board of Directors

    Independent Director Brings Decades of Experience Driving Growth and Value Creation for Iconic Consumer Brands Appointment Reflects Commitment to Ongoing Board Refreshment lululemon athletica inc. (NASDAQ:LULU) today announced the appointment of Chip Bergh, former President and Chief Executive Officer of Levi Strauss & Co., to its Board of Directors, effective immediately. With this addition, lululemon has added five new independent directors to the Board in the last five years, reflecting the Board's commitment to ongoing refreshment. "Chip Bergh is an industry leader with a proven record of guiding successful transformations, overseeing the growth of some of the world's most iconic

    3/17/26 4:05:00 PM ET
    $LULU
    Apparel
    Consumer Discretionary